NRC Health
NRC
$18.62
-$0.31-1.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.88% | -3.96% | -3.50% | -4.08% | -4.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.88% | -3.96% | -3.50% | -4.08% | -4.15% |
| Cost of Revenue | -5.66% | -8.01% | -6.37% | -0.03% | 0.98% |
| Gross Profit | 0.61% | -1.28% | -1.66% | -6.57% | -7.26% |
| SG&A Expenses | 16.94% | 7.75% | 15.86% | 11.02% | -4.92% |
| Depreciation & Amortization | 34.89% | 26.60% | 17.84% | 6.75% | 2.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.01% | 0.47% | 4.24% | 5.03% | -1.45% |
| Operating Income | -25.62% | -17.42% | -25.68% | -28.85% | -11.46% |
| Income Before Tax | -54.99% | -45.41% | -33.53% | -35.63% | -17.70% |
| Income Tax Expenses | -31.74% | -21.02% | -13.57% | -25.25% | -8.78% |
| Earnings from Continuing Operations | -62.68% | -53.19% | -39.58% | -38.74% | -20.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.68% | -53.19% | -39.58% | -38.74% | -20.27% |
| EBIT | -25.62% | -17.42% | -25.68% | -28.85% | -11.46% |
| EBITDA | -16.67% | -11.02% | -19.71% | -24.17% | -9.61% |
| EPS Basic | -62.08% | -52.07% | -37.46% | -36.74% | -17.19% |
| Normalized Basic EPS | -30.13% | -20.76% | -29.54% | -32.60% | -13.99% |
| EPS Diluted | -62.89% | -52.95% | -37.74% | -36.92% | -16.80% |
| Normalized Diluted EPS | -30.18% | -20.63% | -29.35% | -32.37% | -13.64% |
| Average Basic Shares Outstanding | -5.90% | -5.56% | -4.99% | -4.17% | -3.62% |
| Average Diluted Shares Outstanding | -5.84% | -5.71% | -5.24% | -4.51% | -4.01% |
| Dividend Per Share | 16.67% | 8.33% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.80% | 1.05% | 0.59% | -0.50% | -0.61% |